• 1
    Simons JN, Leary TP, Dawson GJ, Pilot-Matias TJ, Muerhoff AS, Schlauder GG, Desai SM, Mushahwar IK. Isolation of novel virus-like sequences associated with human hepatitis. Nature Med 1995; 1: 5649.
  • 2
    Linnen J, Wages J, Zhang-Keck Z-Y, Fry KE, Krawczynski KZ, Alter H, Koonin E, Gallagher M, Alter M, Hadziyannis S, Karayiannis P, Fung K, et al. Molecular cloning and disease association of hepatitis G virus: A transfusion-transmissible agent. Science 1996; 271: 5058.
  • 3
    Viswanatha DS, Dogan A. Hepatitis C virus and lymphoma. J Clin Pathology 2007; 60: 137883.
  • 4
    Dal Maso L, Franceschi S. Hepatitis C virus and risk of lymphoma and other lymphoid neoplasms: a meta-analysis of epidemiologic studies. Cancer Epidemiol Biomarkers Prev 2006; 15: 207885.
  • 5
    Stapleton JT. GB virus type C/Hepatitis G virus. Semin Liver Dis 2003; 23: 13748.
  • 6
    Mohr EL, Stapleton JT. GB virus type C interactions with HIV: The role of envelope glycoproteins. J Viral Hepat 2009; 16: 75768.
  • 7
    Krajden M, Yu A, Braybrook H, Lai AS, Mak A, Chow R, Cook D, Tellier R, Petric M, Gascoyne RD, Connors JM, Brooks-Wilson AR, et al. GBV-C/hepatitis G virus infection and non-hodgkin lymphoma: A case control study. Int J Cancer 2009; In Press.
  • 8
    Alter HJ. G-pers creepers, where'd you get those papers? A reassessment of the literature on the hepatitis G virus. Transfusion 1997; 37: 56972.
  • 9
    Sullivan MT, Cotten R, Read EJ, Wallace EL. Blood collection and transfusion in the United States in 2001. Transfusion 2007; 47: 38594.
  • 10
    Fogeda M, Navas S, Martin J, Casqueiro M, Rodriguez E, Arocena C, Carreno V. In vitro infection of human peripheral blood mononuclear cells by GB virus C/Hepatitis G virus. J Virol 1999; 73: 405261.
  • 11
    Laskus T, Radkowski M, Wang LF, Vargas H, Rakela J. Detection of hepatitis G virus replication sites by using highly strand-specific Tth-based reverse transcriptase PCR. J Virol 1998; 72: 30725.
  • 12
    George SL, Varmaz D, Stapleton JT. GB virus C replicates in primary T and B lymphocytes. J Infect Dis 2006; 193: 4514.
  • 13
    Hill AB. The environment and disease: association or causation? Proc R Soc Med 1965; 58: 295300.
  • 14
    Moenkemeyer M, Schmidt RE, Wedemeyer H, Tillmann HL, Heiken H. GBV-C coinfection is negatively correlated to Fas expression and Fas-mediated apoptosis in HIV-1 infected patients. J Med Virol 2008; 80: 193340.
  • 15
    McLinden JH, Kaufman T, Xiang J, Chang Q, Stapleton JT. HCV and GBV-C NS5A proteins inhibit Fas-mediated apoptosis in CD4+ T cell lines. 14th International Symposium on Hepatitis C virus and related viruses Glasgow, Scotland 2007;September 9-13.
  • 16
    Xiang J, McLinden JH, Rydze RA, Chang Q, Kaufman TM, Klinzman D, Stapleton JT. Viruses within the Flaviviridae decrease CD4 expression and inhibit HIV replication in human CD4+ cells. J Immunol 2010; In press.
  • 17
    Nunnari G, Nigro L, Palermo F, Attanasio M, Berger A, Doerr HW, Pomerantz RJ, Cacopardo B. Slower Progression of HIV-1-Infection in persons with GB Virus C co-infection correlates with an intact T-Helper 1 cytokine profile. Ann Int Med 2003; 139: 2630.
  • 18
    Xiang J, Rydze RA, Chang Q, Allen JB, McLinden JH, Stapleton JT. GB virus C infection and NS5A protein promote a Th1 cytokine profile in lymphocytes. General 107th Meeting of the Am Soc Microbiol. Toronto, 2007.
  • 19
    Xiang J, George SL, Wunschmann S, Chang Q, Klinzman D, Stapleton JT. Inhibition of HIV-1 replication by GB virus C infection through increases in RANTES, MIP-1α, MIP-1β, and SDF-1. Lancet 2004; 363: 20406.
  • 20
    Dammaco F, Sansonno D, Piccoli C, Tucci FA, Racanelli V. The cryoglobulins: an overview. Eur J Clin Invest 2001; 31: 62838.
  • 21
    Machida K, Cheng KT, Sung VM, Shimodaira S, Lindsay KL, Levine AM, Lai MY, Lai MM. Hepatitis C virus induces a mutator phenotype: enhanced mutations of immunoglobulin and protoncogens. Proc Natl Acad Sci U S A 2004; 101: 42627.
  • 22
    Xiang J, McLinden JH, Chang Q, Kaufman TM, Stapleton JT. An 85 amino acid segment of the GB Virus type C NS5A phosphoprotein inhibits HIV-1 replication in CD4+ Jurkat T-cells. Proc Natl Acad Sci U S A 2006; 103: 155705.
  • 23
    Maidana Giret MT, Silva TM, Sauer MM, Tomiyama H, Levi JE, Bassichetto KC, Nishiya A, iaz RS, abino EC, alacios R, allas EG. GBV-C infection modulates T cell activation in recently HIV-infected subjects and is independent of HIV-1 viral load. AIDS 2009; 23: 227787.
  • 24
    Muller AMD, Ihorst S, Mertelsmann R, Engelhardt M. Epidemiology of non-Hodgkin's lymphoma (NHL): trends, geographic distribution, and etiology. Annals of Hematology 2005; 84: 112.
  • 25
    Heuft HG, Berg T, Schreier E, Kunkel U, Tacke M, Schwella N, Hopf U, Salama A, Huhn D. Epidemiological and clinical aspects of hepatitis G virus infection in blood donors and immunocompromised recipients of HGV-contaminated blood. Vox Sanguinis 1998; 74: 1617.
  • 26
    Donato F, Boffetta P, Puoti M. A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma. Int J Cancer 1998; 75: 34754.
  • 27
    Xiang J, Klinzman D, McLinden J, Schmidt WN, LaBrecque DR, Gish R, Stapleton JT. Characterization of hepatitis G virus (GB-C Virus) particles: Evidence for a nucleocapsid and expression of sequences upstream of the E1 protein. J Virol 1998; 72: 273844.
  • 28
    Perez-Lopez S, Vila-Romeu N, Alsina Esteller MA, Espina M, Haro I, Mestres C. Interaction of GB Virus C/Hepatitis G Virus Synthetic Peptides with Lipid Langmuir Monolayers and Large Unilamellar Vesicles. J Phys Chem B 2009 113: 319-27.